RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Embla Medical hf Stock

Embla Medical hf Revenue 2025

Embla Medical hf Revenue

968.97 M USD

Ticker

EMBLA.CO

ISIN

IS0000000040

WKN

755122

In 2025, Embla Medical hf's sales reached 968.97 M USD, a 11.36% difference from the 870.09 M USD sales recorded in the previous year.

The Embla Medical hf Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e1.3735,55
2028e1.2538,97
2027e1.1442,41
2026e1.0347,10
2025e0.9750,11
2024e0.8755,81
20230.7961,80
20220.7261,19
20210.7263,37
20200.6362,15
20190.6963,92
20180.6163,11
20170.5762,39
20160.5263,07
20150.4862,75
20140.5163,43
20130.4461,86
20120.462,09
20110.462,07
20100.3662,09
20090.3361,04
20080.3558,97
20070.3458,31
20060.2559,26
20050.1658,74
20040.1260,13

Embla Medical hf Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Embla Medical hf, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Embla Medical hf from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Embla Medical hf’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Embla Medical hf. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Embla Medical hf’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Embla Medical hf’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Embla Medical hf’s growth potential.

Embla Medical hf Revenue, EBIT and net profit per share

DateEmbla Medical hf RevenueEmbla Medical hf EBITEmbla Medical hf Net Income
2029e1.37 B undefined235.87 M undefined181.61 M undefined
2028e1.25 B undefined210.17 M undefined160.02 M undefined
2027e1.14 B undefined187.2 M undefined118.62 M undefined
2026e1.03 B undefined159.91 M undefined112.32 M undefined
2025e968.97 M undefined141.88 M undefined94.7 M undefined
2024e870.09 M undefined121.03 M undefined82.59 M undefined
2023785.68 M undefined89.39 M undefined58.39 M undefined
2022718.65 M undefined64.84 M undefined42.51 M undefined
2021718.67 M undefined97.43 M undefined63.99 M undefined
2020629.5 M undefined45.66 M undefined6.21 M undefined
2019686.26 M undefined97.72 M undefined66.04 M undefined
2018612.88 M undefined78.92 M undefined79.75 M undefined
2017568.62 M undefined74.82 M undefined57.65 M undefined
2016520.75 M undefined72.17 M undefined51.03 M undefined
2015483.03 M undefined77.34 M undefined51.24 M undefined
2014509.4 M undefined85.9 M undefined59.4 M undefined
2013436.3 M undefined60.2 M undefined40.5 M undefined
2012399.4 M undefined56.8 M undefined38.5 M undefined
2011401.3 M undefined60.6 M undefined35.3 M undefined
2010358.5 M undefined59 M undefined34.9 M undefined
2009330.6 M undefined48.2 M undefined22.7 M undefined
2008350 M undefined47.6 M undefined28.5 M undefined
2007335.6 M undefined39.7 M undefined7.6 M undefined
2006252.1 M undefined28.2 M undefined4.4 M undefined
2005160.7 M undefined20.9 M undefined11.7 M undefined
2004124.4 M undefined20.4 M undefined15.2 M undefined

Embla Medical hf stock margins

The Embla Medical hf margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Embla Medical hf. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Embla Medical hf.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Embla Medical hf's sales revenue. A higher gross margin percentage indicates that the Embla Medical hf retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Embla Medical hf's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Embla Medical hf's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Embla Medical hf's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Embla Medical hf. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Embla Medical hf's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Embla Medical hf Margin History

Embla Medical hf Gross marginEmbla Medical hf Profit marginEmbla Medical hf EBIT marginEmbla Medical hf Profit margin
2029e61.8 %17.27 %13.29 %
2028e61.8 %16.87 %12.84 %
2027e61.8 %16.35 %10.36 %
2026e61.8 %15.51 %10.89 %
2025e61.8 %14.64 %9.77 %
2024e61.8 %13.91 %9.49 %
202361.8 %11.38 %7.43 %
202261.19 %9.02 %5.92 %
202163.37 %13.56 %8.9 %
202062.15 %7.25 %0.99 %
201963.92 %14.24 %9.62 %
201863.11 %12.88 %13.01 %
201762.39 %13.16 %10.14 %
201663.07 %13.86 %9.8 %
201562.75 %16.01 %10.61 %
201463.43 %16.86 %11.66 %
201361.86 %13.8 %9.28 %
201262.09 %14.22 %9.64 %
201162.07 %15.1 %8.8 %
201062.09 %16.46 %9.74 %
200961.04 %14.58 %6.87 %
200858.97 %13.6 %8.14 %
200758.31 %11.83 %2.26 %
200659.26 %11.19 %1.75 %
200558.74 %13.01 %7.28 %
200460.13 %16.4 %12.22 %

Embla Medical hf Aktienanalyse

What does Embla Medical hf do?

Ossur hf is an Icelandic company specializing in the development and manufacturing of orthopedic products. The company was founded in 1971 by Orn Ragnarsson and has since brought many innovative products to the market. The company is headquartered in Reykjavik, Iceland, and operates in more than 30 countries worldwide. Furthermore, the company collaborates with partners and distributors from around the world. Ossur's products are intended for people with amputations, injuries, or chronic pain. Ossur's business model is to develop and manufacture high-quality, innovative solutions for the orthopedic industry. Ossur's products aim to improve the mobility, comfort, and quality of life for people with disabilities and injuries. Ossur operates in three main divisions: prosthetics, braces, and motion analysis. The prosthetics division focuses on the development of artificial limbs for people who have undergone amputation. The braces division focuses on the development of products such as knee braces, back braces, and ankle braces to support people with injuries or chronic pain. The motion analysis division focuses on the development of products such as motion measurement systems and gait analysis devices to assist orthopedic experts in diagnosing and treating patients. One of Ossur's most well-known products is the "Flex-Foot" leg prosthesis. The design of this prosthesis is based on the natural movements of a human foot and is a milestone in prosthetic development. Another innovative product from Ossur is the "Rheo" knee joint system, which is based on artificial intelligence and allows the user to walk more naturally. In recent years, Ossur has also expanded its product portfolio to the field of sports. The company has developed a range of products to help athletes improve their performance, avoid injuries, and heal faster. Overall, Ossur has shown in recent years that the company is always looking for new opportunities to develop innovative solutions in the field of orthopedics. Through a focus on research and development and collaboration with leading orthopedic experts, Ossur has established itself as a key player in the market. Embla Medical hf ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Embla Medical hf's Sales Figures

The sales figures of Embla Medical hf originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Embla Medical hf’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Embla Medical hf's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Embla Medical hf’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Embla Medical hf stock

How much revenue did Embla Medical hf generate this year?

Embla Medical hf has achieved a revenue of 968.97 M USD this year.

How much was the turnover of the company Embla Medical hf compared to the previous year?

The revenue of Embla Medical hf has increased by 11.36% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Embla Medical hf?

The revenue of Embla Medical hf is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Embla Medical hf measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Embla Medical hf so important for investors?

The revenue of Embla Medical hf is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Embla Medical hf pay?

Over the past 12 months, Embla Medical hf paid a dividend of 0.15 USD . This corresponds to a dividend yield of about 3.17 %. For the coming 12 months, Embla Medical hf is expected to pay a dividend of 1.49 USD.

What is the dividend yield of Embla Medical hf?

The current dividend yield of Embla Medical hf is 3.17 %.

When does Embla Medical hf pay dividends?

Embla Medical hf pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Embla Medical hf?

Embla Medical hf paid dividends every year for the past 6 years.

What is the dividend of Embla Medical hf?

For the upcoming 12 months, dividends amounting to 1.49 USD are expected. This corresponds to a dividend yield of 31.45 %.

In which sector is Embla Medical hf located?

Embla Medical hf is assigned to the 'Health' sector.

Wann musste ich die Aktien von Embla Medical hf kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Embla Medical hf from 3/26/2020 amounting to 0.15 USD, you needed to have the stock in your portfolio before the ex-date on 3/13/2020.

When did Embla Medical hf pay the last dividend?

The last dividend was paid out on 3/26/2020.

What was the dividend of Embla Medical hf in the year 2024?

In the year 2024, Embla Medical hf distributed 0 USD as dividends.

In which currency does Embla Medical hf pay out the dividend?

The dividends of Embla Medical hf are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Embla Medical hf

Our stock analysis for Embla Medical hf Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Embla Medical hf Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.